Drug · DIN 01926292
PANECTYL
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since October 31, 2024; first marketed December 31, 1959.
- Drug Identification Number (DIN)
- 01926292
- Company (DIN owner)
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Alimemazine R06AD01
- Class
- Human
- Record last updated
- August 4, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRIMEPRAZINE (TRIMEPRAZINE TARTRATE) | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 20, 2022: NOC 29244New Drug Submission (NDS) · Administrative: Change in Product Ownership
- November 28, 2002: NOC 802New Drug Submission (NDS) · Manufacturer name change
- November 14, 2000: NOC 1531New Drug Submission (NDS)
Other DINs named PANECTYL
- DIN 01926306 · Cancelled Post Market